News
University of Edinburgh spinout Cellinta will develop gene therapies for cancer
A biotech company spun out of the University of Edinburgh will utilise research to develop new gene therapies to target different types of cancer.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
A biotech company spun out of the University of Edinburgh will utilise research to develop new gene therapies to target different types of cancer.